diabetes mellitus

Related by string. Diabetes Mellitus * DIABETES : diabetes cardiovascular disease / Mellitus : Diabetes mellitus * gestational diabetes mellitus . diabetes mellitus hypertension . diabetes mellitus DM . Diabetes mellitus type . onset diabetes mellitus . hypertension diabetes mellitus . diabetes mellitus T2DM . gestational diabetes mellitus GDM . diabetes mellitus NIDDM *

Related by context. All words. (Click for frequent words.) 74 diabetes 73 diabetes mellitus T2DM 70 diabetes mellitus DM 70 hypertension 68 hypercholesterolemia 68 T2DM 68 impaired glucose tolerance 68 metabolic syndrome 67 Diabetes Mellitus 66 elevated triglyceride levels 66 glucose intolerance 66 2 diabetes T2D 66 onset diabetes 66 dyslipidemia 65 macrovascular disease 65 T1DM 65 diabetic nephropathy 65 microalbuminuria 65 nephropathy 65 cardiovascular disease 65 hyperglycaemia 64 onset diabetes mellitus 64 hyperglycemia 64 dyslipidaemia 64 NAFLD 64 macroalbuminuria 64 elevated triglycerides 63 lipid abnormalities 63 subclinical hypothyroidism 63 insulin resistance 63 HbA1c levels 63 hypertensives 63 MetS 63 1 diabetes T1D 63 arterial hypertension 63 atherogenic dyslipidemia 63 gestational diabetes mellitus 63 systemic lupus erythematosus 62 renal insufficiency 62 systemic lupus erythematosus SLE 62 cardiovascular disease CVD 62 von Willebrand disease 62 diabetes dyslipidemia 62 lipid levels 62 coronary artery disease 62 IDDM 62 diabetes mellitus NIDDM 62 coronary heart 61 Diabetes mellitus 61 juvenile idiopathic arthritis JIA 61 systolic hypertension 61 cardiovascular mortality 61 hypercholesterolaemia 61 myocardial infarction 61 elevated fasting glucose 61 overt nephropathy 61 proliferative retinopathy 61 co morbidities 61 fasting glucose levels 61 hypertriglyceridemia 61 microvascular complications 61 familial hypercholesterolemia 61 proteinuria 61 hyperlipidemia 61 dysglycemia 61 triglyceride levels 61 glycemic control 60 serum phosphate 60 variceal bleeding 60 hypertension diabetes mellitus 60 left ventricular dysfunction 60 proliferator activated receptor 60 coronary disease 60 primary hypercholesterolemia 60 gallstone disease 60 Metabolic Syndrome 60 hyperinsulinemia 60 AAT deficiency 60 delta gamma agonist 60 Prehypertension 60 proliferative diabetic retinopathy 60 preserved ejection fraction 60 hyperlipidaemia 60 diabetic retinopathy 60 antihypertensive therapy 60 intermittent claudication 60 lupus erythematosus 60 GH deficiency 60 elevated LDL cholesterol 60 diabetes NIDDM 60 subclinical hyperthyroidism 60 HeFH 60 diabetes mellitus hypertension 59 comorbidities 59 prediabetes 59 diabetes cardiovascular disease 59 Severe Primary IGFD 59 lactic acidosis 59 pericardial effusion 59 normotensive 59 2 diabetes UKPDS 59 CTEPH 59 thyrotoxicosis 59 glycosylated hemoglobin HbA1c 59 impaired fasting glucose 59 SHPT 59 chronic HCV infection 59 cerebral infarction 59 neovascular AMD 59 glycated hemoglobin levels 59 autonomic dysfunction 59 HNSCC 59 PAOD 59 hyperuricemia 59 renal dysfunction 59 colorectal adenoma 59 CHD mortality 59 atherosclerosis 59 hyperkalemia 59 pulmonary hypertension PH 59 nonalcoholic steatohepatitis NASH 59 idiopathic 59 rheumatic disease 59 cardiovascular disease hypertension 59 atrophic gastritis 59 T2D 59 insulin resistance syndrome 59 comorbid conditions 59 serum cholesterol 59 folate deficiency 59 β blockers 59 decompensated heart failure 59 nondiabetic 59 prehypertension 59 hypercalcemia 59 hypertension dyslipidemia 59 diabetes hyperlipidemia 59 atherosclerotic cardiovascular disease 59 diabetic kidney 59 polyarticular 59 hepatorenal syndrome 59 systolic dysfunction 59 parkinsonism 58 abnormal glucose tolerance 58 peripheral arterial disease 58 open angle glaucoma 58 disease NAFLD 58 vertebral fracture 58 secondary hyperparathyroidism 58 urolithiasis 58 macrovascular complications 58 adiposity 58 NYHA Class II 58 alcoholic fatty liver 58 NIDDM 58 abnormal lipids 58 subclinical atherosclerosis 58 Cardiovascular Risk 58 chronic renal failure 58 knee osteoarthritis 58 haptoglobin 58 inadequate glycemic 58 Complications Trial 58 vascular disease 58 venous thrombosis 58 improves glycemic 58 hereditary hemochromatosis 58 severe hypoglycemia 58 mixed hyperlipidemia 58 primary generalized tonic 58 left ventricular hypertrophy 58 Insulin resistance 58 atherosclerotic disease 58 autoimmune thyroid 58 AA Amyloidosis 58 gestational diabetes 58 LUTS 58 acute coronary syndrome 58 abdominal adiposity 58 renal disease 58 sodium glucose cotransporter 58 NNT = 58 vWD 58 postoperative AF 58 diastolic heart 58 atherothrombotic events 58 hyperparathyroidism 58 retinopathy 58 coronary revascularization 58 diabetic gastroparesis 58 diabetic 58 liver cirrhosis 58 primary aldosteronism 58 knee OA 58 hypophosphatemia 58 metabolic abnormalities 57 acute coronary syndromes 57 polycystic ovary syndrome PCOS 57 rheumatoid 57 elevated CRP 57 atherothrombosis 57 triglyceride concentrations 57 ADPKD 57 homozygous familial hypercholesterolemia 57 MGUS 57 microvascular disease 57 Primary IGFD 57 rheumatoid arthritis RA 57 resistant hypertension 57 nonalcoholic steatohepatitis 57 hepatocellular carcinoma 57 multivessel disease 57 serum IGF 57 lupus nephritis 57 breast carcinoma 57 antihypertensive drugs 57 endothelial dysfunction 57 diabetics 57 thyroid dysfunction 57 nonvertebral fractures 57 progressive dyspnea 57 myeloproliferative neoplasms 57 ATACAND 57 NPH insulin 57 paroxysmal AF 57 adrenal insufficiency 57 elevated ALT 57 heterozygous familial 57 pancreatectomy 57 aortic valve stenosis 57 renal impairment 57 juvenile idiopathic arthritis 57 hyperphosphatemia 57 psychiatric morbidity 57 Alzheimer Disease AD 57 hyperbilirubinemia 57 central adiposity 57 hypocalcemia 57 hypovitaminosis D 57 hypertensive patients 57 severe Primary IGFD 57 CVD mortality 57 cryptorchidism 57 amnestic mild cognitive impairment 57 HIV HCV coinfected 57 Impaired Glucose Tolerance 57 thromboembolic 57 recurrent VTE 57 nondiabetic patients 57 gastric carcinoma 57 metabolic disturbances 57 colorectal cancer CRC 57 Diabetic Nephropathy 57 Venous thromboembolism 57 albuminuria 57 heterotaxy 57 AAT Deficiency 57 cardiovascular morbidity 57 arterial stiffness 57 Major Depressive Disorder 57 mixed dyslipidemia 57 hemoglobin A1c HbA1c 57 macrovascular 57 antidiabetic drugs 57 inadequately controlled 57 PsA 57 spinocerebellar ataxia 57 cardiometabolic risk 57 thromboembolic disease 57 thrombotic events 57 hypertensive 57 COPD 57 elevated LDL 57 fasting plasma glucose 57 osteoarthritis 57 Rheumatoid Arthritis RA 57 NYHA class 57 hemoglobin A1c levels 57 Pioglitazone 57 androgen deficiency 57 purpura ITP 57 potentially modifiable 57 Hashimoto thyroiditis 57 NYHA 57 carotid stenosis 57 Aortic stenosis 57 serum lipid levels 57 primary hyperparathyroidism 57 triglycerides 57 neurological manifestations 57 CC genotype 57 glycemia 57 rs# [002] 56 thiazolidinedione 56 abnormal lipid 56 hypoglycemic episodes 56 thromboembolism 56 OAB symptoms 56 grade cervical intraepithelial 56 nonfatal MI 56 Non Alcoholic Fatty 56 lipid lowering agents 56 hypogonadal men 56 extrapyramidal symptoms 56 nontraumatic 56 isolated systolic hypertension 56 HBeAg negative 56 metformin sulfonylurea 56 severe hypoglycaemia 56 partial onset seizures 56 elevated uric acid 56 chronic pancreatitis 56 metformin monotherapy 56 Sjögren syndrome 56 hematopoietic cancers 56 acute myelogenous leukemia AML 56 Systemic Lupus Erythematosus SLE 56 treatment emergent hyperglycemia 56 chronic thromboembolic pulmonary 56 left ventricular systolic 56 postoperative pulmonary 56 Systemic Lupus Erythematosus 56 abdominal obesity 56 acute myocardial infarction 56 serum creatinine levels 56 inflammatory rheumatic 56 heart disease 56 Hypoactive Sexual Desire Disorder 56 POAG 56 myocardial ischemia 56 invasive candidiasis 56 gastric adenocarcinoma 56 subependymal giant cell 56 Thiazolidinediones 56 dopaminergic therapy 56 overactive bladder symptoms 56 chronic HBV infection 56 hypothyroidism 56 Acute Coronary Syndromes ACS 56 HbA 1c 56 NOMID 56 IgA deficiency 56 recurrent acute pancreatitis 56 heparin induced thrombocytopenia 56 contrast induced nephropathy 56 serum uric acid 56 chronic immune thrombocytopenic 56 postoperative atrial fibrillation 56 density lipoprotein cholesterol 56 diabetic microvascular complications 56 carotid atherosclerosis 56 polycystic ovary syndrome 56 hyperphosphataemia 56 ischemic stroke 56 antiarrhythmic drug 56 hypercholesterolemic patients 56 pericardial effusions 56 non alcoholic steatohepatitis 56 endometrial hyperplasia 56 osteoarthritis rheumatoid arthritis 56 SJIA 56 periodontal disease 56 MPGN 56 fasting triglyceride levels 56 serum triglycerides 56 comorbidity 56 neuropathic pain metabolic diseases 56 cognitive impairment 56 metformin 56 neurofibromatosis type 56 Gestational diabetes 56 hyperlipemia 56 congenital deficiency 56 progressive neurodegenerative disorder 56 Non Alcoholic Steatohepatitis 56 liver transplant recipients 56 tumor histology 56 hypopituitarism 56 asplenia 56 anovulatory infertility 56 hematologic toxicity 56 Diabetic nephropathy 56 elevated blood glucose 56 urinary symptoms 56 leukemia AML 56 myocardial infarction MI 56 NATRECOR R 56 magnesium intake 56 pheochromocytoma 56 renal transplantation 56 angina 56 adiponectin concentrations 55 lacunar 55 prediabetic 55 hypercalcaemia 55 carbohydrate intolerance 55 pathologic fractures 55 oral antidiabetic medication 55 GERD 55 statin therapy 55 HRQOL 55 depressive symptomatology 55 recurrent wheezing 55 VUR 55 glitazones 55 cardio metabolic 55 generalized tonic clonic seizures 55 CIMZIA ™ 55 HbA1C 55 hyperlipidemia hypertension 55 neovascular glaucoma 55 acne vulgaris 55 impaired glucose metabolism 55 cardiovascular diseases 55 fatty liver disease 55 primary biliary cirrhosis 55 hyperhomocysteinemia 55 glucocorticoid therapy 55 post thrombotic syndrome 55 essential thrombocythemia 55 terlipressin 55 cystic fibrosis chronic pancreatitis 55 ischemic cardiomyopathy 55 diabetes hypertension 55 thromboembolic complications 55 Ischemic 55 basal cell nevus syndrome 55 prostate cancer CaP 55 familial hypercholesterolemia FH 55 Nonalcoholic Fatty Liver Disease 55 Hypoglycaemia 55 hepatic cirrhosis 55 tolvaptan 55 comorbid anxiety 55 cognitive dysfunction 55 CHD 55 penetrance 55 hypercalciuria 55 fructose intolerance 55 fasting glucose 55 Helicobacter pylori infection 55 liver fibrosis 55 serum folate concentrations 55 APOE e4 55 familial adenomatous polyposis 55 precocious puberty 55 postoperative delirium 55 improves insulin sensitivity 55 Obstructive sleep apnea 55 hyperlipidemic 55 Polycystic Ovary Syndrome 55 chronic kidney 55 Critical Limb Ischemia CLI 55 hypertension hypercholesterolemia 55 atopic disease 55 confidence interval #.#-#.# 55 atopic eczema 55 nondiabetic subjects 55 esophageal squamous cell carcinoma 55 tumor lysis syndrome 55 Anorexia nervosa 55 unfavorable cytogenetics 55 atopy 55 eosinophilic asthma 55 syncope 55 GH deficient 55 cirrhosis 55 genital infections 55 hyperphenylalaninemia HPA due 55 insulin resistance precursor 55 elevated lipase 55 hypothalamic amenorrhea 55 rheumatoid arthritis osteoarthritis ankylosing 55 hypoglycaemic episodes 55 renal artery stenosis 55 skeletal fluorosis 55 bulimia nervosa 55 renovascular hypertension 55 Pulmonary hypertension 55 CRVO 55 antihypertensive medications 55 chronic GVHD 55 neurodevelopmental outcome 55 glycated hemoglobin 55 VaD 55 hepatic steatosis 55 lipohypertrophy 55 DMARD 55 recurrent tonsillitis 55 dysfunctional voiding 55 periodontitis 55 colorectal carcinoma 55 metastatic RCC 55 uric acid levels 55 reflux esophagitis 55 fructose intake 55 tuberous sclerosis TS 55 uncontrolled hypertension 55 acromegaly 55 NYHA Class III 55 retrospective cohort 55 Hypertriglyceridemia 55 venous thromboembolism 55 baseline HbA1c 55 pancreatic insufficiency 55 Proteinuria 55 acute myocardial infarction MI 55 Pulmonary arterial hypertension 55 Tolvaptan 55 monoclonal gammopathy 55 IPAH 55 lower extremity amputation 55 hypokalemia 55 reflux symptoms 55 antihypertensive medication 55 Diabetic neuropathy 55 nondiabetics 55 ALT flares 55 fasting insulin 55 glycated hemoglobin HbA1c 55 HMGA1 55 intravesical therapy 55 elevated IOP 55 rheumatic diseases 55 lipid lowering therapy 55 osteogenesis imperfecta disorder 55 etiology 55 recurrent stroke 55 posttransplant 55 ventricular remodeling 55 systemic corticosteroid 55 lipid disorders 55 orthostatic hypotension 55 Prediabetes 55 juvenile myoclonic epilepsy 55 atopic 55 thyroiditis 55 Alzheimer disease AD 55 valvular heart disease 55 type2 diabetes 55 gestational diabetes mellitus GDM 55 psoriatic arthritis PsA 55 LDL C 55 C reactive protein 55 fetuin 55 density lipoprotein HDL cholesterol 55 ischemic complications 55 comorbid depression 55 nonischemic 55 macrovascular events 55 idiopathic generalized epilepsy 55 oesophageal adenocarcinoma 55 serum urate levels 55 myeloproliferative diseases 55 femoral neck fracture 55 gout 55 symptomatic BPH 55 retinal vein occlusion 54 biphasic insulin aspart 54 diabetic neuropathy 54 angina pectoris 54 onset seizures 54 Critical limb ischemia 54 cardiac insufficiency 54 aHUS 54 chronic ITP 54 Major depressive disorder 54 Victoza R 54 Arch Intern Med 54 haemorrhagic stroke 54 CLA supplementation 54 neoplasm 54 Hypertension 54 hypoglycemia 54 SGPT 54 cardiac dysfunction 54 MYH9 gene 54 NYHA Class 54 congenital malformations 54 adrenalectomy 54 EXJADE 54 APOE genotype 54 dietary calcium intake 54 hyperammonemia 54 hyperprolactinemia 54 LV dysfunction 54 Chronic Heart Failure 54 Vitamin D insufficiency 54 arterial thrombosis 54 hyperoxaluria 54 idiopathic thrombocytopenic purpura 54 serum leptin 54 blood lipids 54 % CI #.#-#.# [006] 54 Haptoglobin 54 unknown etiology 54 glaucoma 54 anorexia nervosa 54 NATRECOR ® 54 serum calcium levels 54 obstructive sleep apnea 54 unstable angina pectoris 54 obesity sedentary lifestyle 54 IV NSCLC 54 colorectal liver metastases 54 occlusive disease 54 Hb A1C 54 metformin sulfonylureas 54 necrotizing pancreatitis 54 iron overload 54 relapsing remitting 54 cerebrovascular accident 54 interstitial pneumonia 54 rheumatoid arthritis 54 antithrombotic therapy 54 prehypertensive 54 acetabular dysplasia 54 sulphonylurea 54 albumin excretion 54 esophagitis 54 cerebrovascular disease 54 Nephrol Dial Transplant 54 amenorrhoea 54 LHON 54 hydroxyvitamin D levels 54 serum lipids 54 esophageal adenocarcinoma 54 hepatic insufficiency 54 salmeterol HFA MDI 54 prepubertal 54 adiponectin levels 54 valvular disease 54 NYHA functional class 54 ocular hypertension 54 hypoparathyroidism 54 aminotransferase levels 54 Acute Myeloid Leukaemia AML 54 Vitamin B# deficiency 54 prognostic variables 54 lichen planus 54 cerebral vasospasm 54 OADs 54 CKD Stage 54 atherothrombotic disease 54 autosomal dominant 54 hypertension congestive heart 54 Parkinson disease PD 54 CI #.#-#.# [001] 54 hereditary predisposition 54 Impaired glucose tolerance 54 gestational hypertension 54 AGHD 54 fasting hyperglycemia 54 heterozygous FH 54 Sleep disordered breathing 54 6R BH4 54 modifiable risk 54 Fatty Liver Disease 54 severe renal impairment 54 HIVAN 54 Ankylosing spondylitis 54 pathophysiologic 54 postoperative mortality 54 enteroviral infection 54 glycosylated hemoglobin 54 reflux disease 54 urinary incontinence UI 54 Buerger Disease 54 rFVIIa 54 NKX2 54 dyslipidemias 54 dietary intakes 54 islet autoimmunity 54 gliclazide 54 untreated celiac disease 54 atopic dermatitis 54 diabetic retinopathy DR 54 embolic stroke 54 serum triglyceride levels 54 onset atrial fibrillation 54 chronic idiopathic urticaria 54 plasminogen activator inhibitor 54 blood glucose levels 54 nocturnal hypoglycaemia 54 Osteoarthritis OA 54 HBV infection 54 MPS VI 54 colorectal adenomas 54 airway hyperresponsiveness 54 acarbose 54 ABCB1 54 hemolytic anemia 54 oral antidiabetic drugs 54 IGFD 54 liver histology 54 TNF antagonist 54 intracerebral haemorrhage 54 fragility fracture 54 prostate carcinogenesis 54 hypogonadism 54 glucose tolerance 54 PGTC seizures 54 posaconazole 54 systemic juvenile idiopathic 54 HCV SPRINT 54 gallbladder disease 54 chronic periodontitis 54 olmesartan 54 neuropsychiatric symptoms 54 symptomatic VTE 54 insulin sensitivity 54 otitis media 54 lipid profiles 54 dual PPAR peroxisome 54 Hyperglycemia 54 claudication 54 renal scarring 54 attention-deficit/hyperactivity disorder ADHD 54 idiopathic PAH 54 transferrin saturation 54 antidiabetic medication 54 poor metabolizers 54 vascular dysfunction 54 Insulin detemir 54 elevated serum creatinine 54 congenital anomalies 54 fragility fractures 54 CMV infection 54 thyrotropin 54 pancreatic adenocarcinoma 54 neovascular 54 renal function 54 LQTS 54 mellitus 54 major depressive disorder 54 Hypoglycemia 54 Sjogren syndrome 54 Hp2 2 54 disease CHD 54 Fasting glucose 54 HbA1c 54 autoantibody positive 54 intact parathyroid hormone 54 adenoma 54 Polycystic ovary syndrome PCOS 54 somatostatin analogs 54 coronary calcification 54 generalized edema 54 fibromyalgia syndrome 54 follicular lymphoma FL 54 neurodevelopmental outcomes 54 atrial fibrillation 54 HDL C 54 % CI #.#-#.# [004] 54 myocardial infarction stroke 54 kidney disease 54 thiazolidinediones TZDs 54 alanine aminotransferase 54 gastric cancer 54 airflow obstruction 54 Acute Coronary Syndrome 54 leiomyomas 54 GnRH agonist 54 diabetes insipidus 54 hypoglycemic events 54 tumor recurrence 54 recurrent DVT 54 hypervolemic hyponatremia 54 subclinical 54 haematologic 54 Gaucher disease 54 pharmacologic intervention 54 Neovascular Age Related Macular 54 HbA 1c levels 54 aneurysmal subarachnoid hemorrhage 54 cardio vascular disease 54 aspirin therapy 54 abdominal irradiation 54 alcoholic hepatitis 54 autoimmune thyroiditis 54 rhinosinusitis 54 postmenopausal breast cancer 54 insulin resistant 54 GERD symptoms 54 chronic eosinophilic leukemia 54 Complication rates 54 nephrolithiasis 54 Candesartan 54 Hyperphosphatemia 54 multisystem disease 54 atherothrombotic 54 MMSE scores 54 lymphocytosis 53 glucose lowering 53 vasculopathy 53 histologic subtype 53 NNRTI resistance 53 Elitek 53 Nonalcoholic fatty liver 53 venous blood clots 53 methimazole 53 aminotransferases 53 hepatic impairment 53 G6PD deficiency 53 hypogonadotropic hypogonadism 53 HCV genotype 53 Irritable bowel syndrome 53 nephritis 53 PPAR gamma agonist 53 Alzheimers disease 53 herpes zoster 53 acute myocardial infarction AMI 53 neuropathies 53 laboratory abnormalities 53 stage IIIB 53 inflammatory polyarthritis 53 LDL cholesterol levels 53 atherosclerotic vascular disease 53 LVEF 53 herpes zoster shingles 53 smoldering multiple myeloma 53 acute GVHD 53 microvascular dysfunction 53 CTAP# Capsules 53 beta blocker therapy 53 pyelonephritis 53 carcinoid tumors 53 myelodysplastic syndrome MDS 53 severe periodontitis 53 mildly symptomatic 53 CrCl 53 ADHF 53 metabolic syndrome MetS 53 mm Hg systolic 53 artery stenosis 53 thromboembolic events 53 EoE 53 Glucocorticoids 53 Syncria R 53 valsartan amlodipine 53 umol L 53 TEAEs 53 Ranolazine 53 colorectal polyps 53 Diabetologia 53 polyp recurrence 53 genitourinary GU 53 HOMA IR 53 antidiabetic medications 53 cinacalcet 53 morphometric vertebral fractures 53 perioperative complications 53 metastatic disease 53 biochemical recurrence 53 uveitis 53 Mitral regurgitation 53 patients undergoing percutaneous 53 lowest tertile 53 euthyroid 53 serum phosphate levels 53 urinary incontinence 53 Niemann Pick disease 53 cystatin C 53 hyperthyroidism 53 systolic blood pressures 53 Hypogonadism 53 Sarcopenia 53 glomerulonephritis 53 PPAR gamma agonists 53 sensorineural hearing loss 53 comorbid psychiatric disorders 53 psychiatric comorbidity 53 advanced adenoma 53 PSN# [002] 53 IGFBP 53 preeclampsia 53 intracranial hypertension 53 non valvular atrial 53 STRIDE PD 53 myelodysplastic syndromes MDS 53 paraneoplastic 53 varicocele 53 Heterozygous Familial Hypercholesterolemia 53 osteoarthritis OA 53 Neovascular AMD 53 Chronic Kidney Disease 53 geographic atrophy 53 thiazide diuretics 53 optic neuropathy 53 Insulin sensitivity 53 SCr 53 gouty arthritis 53 bacterial prostatitis 53 dyslipidemia hypertension 53 psychiatric comorbidities 53 Leber congenital amaurosis LCA 53 Rheumatoid arthritis RA 53 intracranial hemorrhage ICH 53 microangiopathy 53 homozygous FH 53 generalized epilepsy 53 glargine 53 thyrotropin levels 53 familial pancreatic cancer 53 PCa 53 systolic BP 53 LDL cholesterol concentrations 53 hepatocellular carcinomas 53 oral antidiabetic agents 53 carotid IMT 53 PNH patients 53 insulin sensitizing drugs 53 fibrotic disease 53 unstable angina 53 sickle cell disease 53 Helicobacter pylori eradication 53 rhIGF 53 serum PTH 53 pioglitazone 53 invasive aspergillosis 53 aortic dissections 53 adjunctive ABILIFY 53 stable angina 53 nonalcoholic fatty liver 53 endotoxemia 53 Juvenile Idiopathic Arthritis 53 platelet reactivity 53 HRQL 53 SIADH 53 SSc 53 dysthymia 53 Generalized anxiety disorder 53 nonmelanoma skin cancer 53 amnestic MCI 53 venous thromboembolism VTE 53 complement inhibitor eculizumab 53 cytomegalovirus infection 53 DCCT 53 Infusion Reactions Severe 53 androgenetic alopecia 53 retinopathy nephropathy 53 malignant lymphoma 53 androgen deprivation 53 Zollinger Ellison syndrome 53 Exacerbations 53 thiazide diuretic 53 polycystic ovarian syndrome PCOS 53 gastroesophageal reflux 53 APOE gene 53 peptic ulcer 53 #beta hydroxysteroid dehydrogenase 53 granulomatous 53 lower extremity amputations 53 myeloperoxidase 53 cryptogenic stroke 53 pioglitazone HCl 53 delayed gastric emptying 53 bronchopulmonary dysplasia BPD 53 bronchopulmonary dysplasia 53 lysosomal enzyme iduronate 53 tHcy 53 Heavy menstrual bleeding 53 Erythropoietic therapies may 53 Zavesca R 53 Hyperlipidemia 53 abnormal lipid levels 53 Bacterial vaginosis 53 lipodystrophy 53 postoperative morbidity 53 osteoporotic fracture 53 aripiprazole 53 chorioamnionitis 53 microscopic hematuria 53 alagebrium 53 PTEN mutations 53 pathologic fracture 53 subtrochanteric 53 INCB# [003] 53 intravenous bisphosphonates 53 morbidities 53 MYCN amplification 53 G allele 53 genetic variants associated 53 Tardive dyskinesia 53 A1C levels 53 coagulopathy 53 functional dyspepsia 53 antiphospholipid syndrome 53 knee osteoarthritis OA 53 apolipoprotein E 53 hallux valgus 53 acute leukemias 53 neoplastic 53 bronchogenic carcinoma 53 euvolemic 53 cystic lesions 53 hyperinsulinemic 53 osteosarcomas 53 hepatotoxicity

Back to home page